PetMedix logo — R&D stage veterinary therapeutics biotechnology company base...

PetMedix

R&D stage veterinary therapeutics biotechnology company based in Cambridge, UK

Founded 2017 United Kingdom Cambridge, United Kingdom 16 employees Series B Total: $37.00M Biotechnology, Health Care

General Information

Company Name PetMedix
Founded Year 2017
Location United Kingdom Cambridge, United Kingdom +1
Employees 16
Industries Biotechnology, Health Care
Funding Stage Series B
Social

Get notified when PetMedix moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About PetMedix

PetMedix, recognized as an R&D stage veterinary therapeutics biotechnology company, is situated in Cambridge, UK. Founded in 2017, the company has carved a niche in the Biotechnology and Health Care sectors, specializing in innovative treatments for animals.

The company recently announced an upcoming collaboration with Zoetis, a significant transition that may enhance its offerings and market reach.

In terms of funding, PetMedix secured a robust £27.00M Series B investment on 08 September 2021, drawing the attention of prominent investors such as Parkwalk Advisors, Cambridge Innovation Capital, Digitalis Ventures, Kyoritsu Corporation, and Tencent. Such backing underscores the confidence in PetMedix's potential for growth and innovation within the veterinary biotechnology space.

Taxonomy: biotech, veterinary, therapies, scientific methods, pet well-being, longevity, contentment

Services & Products

Development of species-specific therapeutic antibodies
Biotechnology platform for veterinary medicine
Research and development in pet disease treatment

Target Customers

Veterinarians Pet owners Veterinary pharmaceutical companies

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 5
Investor Investor Investor Investor
•••• ••••
08 Sep 2021
Series A •••••• 3
Investor Investor Investor
25 Feb 2019

PetMedix Alternatives & Competitors

PetMedix vs

Zoetis is a global animal health company dedicated to supporting customers and their businesses in e...

42 employees
Biotechnology, Health Care
PetMedix vs
Zoetis
Zoetis United States

Nurturing our world and humankind by advancing care for animals

13444 employees
Biotechnology, Health Care
PetMedix vs
Basepaws
Basepaws United States

Basepaws is a pet genetics company that creates affordable, easy-to-use health tests for every pet p...

Acquired
28 employees
Biotechnology

FAQ About PetMedix

R&D stage veterinary therapeutics biotechnology company based in Cambridge, UK
PetMedix was founded in 2017.
PetMedix is headquartered in Cambridge, United Kingdom.
PetMedix operates in the following industries: Biotechnology, Health Care.
PetMedix has approximately 16 employees.
PetMedix has completed 2 funding rounds, raising a total of $37.00M. The latest funding stage is Series B.
PetMedix offers: Development of species-specific therapeutic antibodies, Biotechnology platform for veterinary medicine, Research and development in pet disease treatment.
Top alternatives and competitors to PetMedix include Zoetis Inc, Zoetis, Basepaws, PHARMAQ part of Zoetis, Folio3 AgTech. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PetMedix and Zoetis Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors PetMedix and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy